Analysis on Bacterial Distribution and Change of Drug Resistance Rate in ICUs Across Southwest China from 2018 to 2022

References

• Murray CJL, Ikuta KS, Sharara F.; Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–655. doi:10.1016/S0140-6736(21)02724-0
   PubMed Web of Science ®Google Scholar
• Wagenlehner FME, Dittmar FR. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Eur Urol. 2022;82(6):658. doi:10.1016/j.eururo.2022.08.023
   PubMed Web of Science ®Google Scholar
• Pulingam T, Parumasivam T, Gazzali AM, et al. Antimicrobial resistance: prevalence, economic burden, mechanisms of resistance and strategies to overcome. Eur J Pharm Sci. 2022;170:106103. doi:10.1016/j.ejps.2021.106103
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–327. doi:10.1016/S1473-3099(17)30753-3
   PubMed Web of Science ®Google Scholar
• Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2022;386(24):2348. doi:10.1056/NEJMx210023
   PubMed Web of Science ®Google Scholar
• Grundmann H, Glasner C, Albiger B, et al. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infect Dis. 2017;17(2):153–163. doi:10.1016/S1473-3099(16)30257-2
   PubMed Web of Science ®Google Scholar
• Gorgulho A, Grilo AM, Figueiredo M, et al. Carbapenemase-producing Enterobacteriaceae in a Portuguese hospital - a five-year retrospective study. Germs. 2020;10(2):95–103. doi:10.18683/germs.2020.1190
   PubMedGoogle Scholar
• Rafailidis PI, Kofteridis D. Proposed amendments regarding the definitions of multidrug-resistant and extensively drug-resistant bacteria. Expert Rev Anti Infect Ther. 2022;20(2):139–146. doi:10.1080/14787210.2021.1945922
   PubMed Web of Science ®Google Scholar
• Munari M, Franzoi F, Sergi M, et al. Extensively drug-resistant and multidrug-resistant gram-negative pathogens in the neurocritical intensive care unit. Acta Neurochir. 2022;164(3):859–865. doi:10.1007/s00701-020-04611-3
   PubMed Web of Science ®Google Scholar
• Kollef MH, Bassetti M, Francois B, et al. The intensive care medicine research agenda on multidrug-resistant bacteria antibiotics and stewardship. Intensive Care Med. 2017;43(9):1187–1197. doi:10.1007/s00134-017-4682-7
   PubMed Web of Science ®Google Scholar
• Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181–1247. doi:10.1007/s00134-021-06506-y
   PubMed Web of Science ®Google Scholar
• Murphy CV, Reed EE, Herman DD, et al. Antimicrobial Stewardship in the ICU. Semin Respir Crit Care Med. 2022;43(1):131–140. doi:10.1055/s-0041-1740977
   PubMedGoogle Scholar
• Pickens CI, Wunderink RG. Principles and practice of antibiotic stewardship in the ICU. Chest. 2019;156(1):163–171. doi:10.1016/j.chest.2019.01.013
   PubMed Web of Science ®Google Scholar
• Kollef MH, Torres A, Shorr AF, et al. Nosocomial Infection. Crit Care Med. 2021;49(2):169–187. doi:10.1097/CCM.0000000000004783
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. CLSI; 2018.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests. CLSI; 2018.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. CLSI; 2022.
   Google Scholar
• CHINET. China's clinical strain detection distribution and drug resistance rate change data. Available from: https://www.chinets.com/Data/GermYear. Accessed March 1, 2023.
   Google Scholar
• Lutgring JD. Carbapenem-resistant Enterobacteriaceae: an emerging bacterial threat. Semin Diagn Pathol. 2019;36(3):182–186. doi:10.1053/j.semdp.2019.04.011
   PubMed Web of Science ®Google Scholar
• Livorsi DJ, Chorazy ML, Schweizer ML, et al. A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States. Antimicrob Resist Infect Control. 2018;7(55):1–9. doi:10.1186/s13756-018-0346-9
   PubMedGoogle Scholar
• Kopotsa K, Sekyere JO, Mbelle NM. Plasmid evolution in carbapenemase-producing Enterobacteriaceae: a review. Ann N Y Acad Sci. 2019;1457(1):61–91. doi:10.1111/nyas.14223
   PubMed Web of Science ®Google Scholar
• Duin D, Lok JJ, Earley M, et al. Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant enterobacteriaceae. Clin Infect Dis. 2018;66(2):163–171. doi:10.1093/cid/cix783
   PubMed Web of Science ®Google Scholar
• Sheu CC, Chang YT, Lin SY, et al. Infections caused by carbapenem-resistant Enterobacteriaceae: an update on therapeutic options. Front Microbiol. 2019;10:80. doi:10.3389/fmicb.2019.00080
   PubMed Web of Science ®Google Scholar
• Tian Y, Zhang QY, Wen LR, et al. Combined effect of Polymyxin B and Tigecycline to overcome heteroresistance in carbapenem-resistant Klebsiella pneumoniae. Microbiol Spectr. 2021;9(2):e0015221. doi:10.1128/Spectrum.00152-21
   PubMed Web of Science ®Google Scholar
• Zhang WX, Guo Y, Yang Y, et al. Study of in vitro synergistic bactericidal activity of dual β-lactam antibiotics against KPC-2-producing Klebsiella pneumonia. Microb Drug Resist. 2020;26(3):204–210. doi:10.1089/mdr.2019.0126
   PubMed Web of Science ®Google Scholar
• Han RR, Shi QY, Wu S, et al. Dissemination of carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) among carbapenem-resistant Enterobacteriaceae isolated from adult and children patients in China. Front Cell Infect Microbiol. 2020;10:314. doi:10.3389/fcimb.2020.00314
   PubMed Web of Science ®Google Scholar
• Wei Q, Sun J, Wang Z, et al. Evaluation of Modified Rapid Carbapenem Inactivation Method (mrCIM) Combined with Rapid EDTA-modified carbapenem inactivation method (reCIM) to detect carbapenemase and distinguish metallo-carbapenemase in Enterobacteriaceae within four hours. Infect Drug Resist. 2020;13:1919–1927. doi:10.2147/IDR.S249570
   PubMed Web of Science ®Google Scholar
• Hu F, Zhu D, Wang F, et al. Current status and trends of antibacterial resistance in China. Clin Infect Dis. 2018;67(s2):S128–S134. doi:10.1093/cid/ciy657
   PubMedGoogle Scholar
• Cong YG, Yang SJ, Rao XC. Vancomycin resistant Staphylococcus aureus infections: a review of case updating and clinical features. J Adv Res. 2019;21:169–176. doi:10.1016/j.jare.2019.10.005
   PubMed Web of Science ®Google Scholar
• Selvabai AP, Sattar SBA, Jayaraman P, et al. Detection and characterisation of heteroresistant vancomycin intermediate Staphylococcus aureus (hVISA) using phenotypic and genotypic methods. J Clin Diagn Res. 2019;13(5):DC01–DC05. doi:10.7860/JCDR/2019/41127.12868
   Web of Science ®Google Scholar
• Wu Q, Sabokroo N, Wang Y, et al. Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates. Antimicrob Resist Infect Control. 2021;10(1):101. doi:10.1186/s13756-021-00967-y
   PubMed Web of Science ®Google Scholar
• Cascioferro S, Carbone D, Parrino B, et al. Therapeutic strategies to counteract antibiotic resistance in MRSA biofilm-associated infections. ChemMedChem. 2021;16(1):65–80. doi:10.1002/cmdc.202000677
   PubMed Web of Science ®Google Scholar